HyTherCaP.: Hydralazine: A new therapeutic approach in Castration Resistant Prostate Carcinoma (Q2906475): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en, pt: Fixing missing labels.) |
(Added qualifier: readability score (P590521): 0.000011549073841409742) |
||||||||||||||
(4 intermediate revisions by the same user not shown) | |||||||||||||||
Property / beneficiary name (string) | |||||||||||||||
Property / beneficiary name (string): INSTITUTO PORTUGUÊS DE ONCOLOGIA DO PORTO FRANCISCO GENTIL - E.P.E. / rank | |||||||||||||||
Property / beneficiary | |||||||||||||||
Property / beneficiary: Q2997125 (Deleted Item) / rank | |||||||||||||||
Property / budget | Property / budget | ||||||||||||||
| 239,998.85 Euro
| ||||||||||||||
Property / EU contribution | Property / EU contribution | ||||||||||||||
| 203,999.02 Euro
| ||||||||||||||
Property / co-financing rate | |||||||||||||||
| |||||||||||||||
Property / co-financing rate: 85.0 percent / rank | |||||||||||||||
Property / summary: None (English) / qualifier | |||||||||||||||
readability score: 0.000011549073841409742
| |||||||||||||||
Property / priority axis | |||||||||||||||
Property / priority axis: Strengthening research, technological development and innovation (OT1) / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / co-financing rate | |||||||||||||||
85.0 percent
| |||||||||||||||
Property / co-financing rate: 85.0 percent / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / thematic objective | |||||||||||||||
Property / thematic objective: Research and innovation / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / beneficiary | |||||||||||||||
Property / beneficiary: INSTITUTO PORTUGUÊS DE ONCOLOGIA DO PORTO FRANCISCO GENTIL - E.P.E. / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / beneficiary name (string) | |||||||||||||||
INSTITUTO PORTUGUÊS DE ONCOLOGIA DO PORTO FRANCISCO GENTIL - E.P.E. | |||||||||||||||
Property / beneficiary name (string): INSTITUTO PORTUGUÊS DE ONCOLOGIA DO PORTO FRANCISCO GENTIL - E.P.E. / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / date of last update | |||||||||||||||
14 November 2023
| |||||||||||||||
Property / date of last update: 14 November 2023 / rank | |||||||||||||||
Normal rank |
Latest revision as of 09:43, 7 March 2024
Project Q2906475 in Portugal
Language | Label | Description | Also known as |
---|---|---|---|
English | HyTherCaP.: Hydralazine: A new therapeutic approach in Castration Resistant Prostate Carcinoma |
Project Q2906475 in Portugal |
Statements
203,999.02 Euro
0 references
239,998.85 Euro
0 references
85.0 percent
0 references
1 January 2018
0 references
30 June 2021
0 references
INSTITUTO PORTUGUÊS DE ONCOLOGIA DO PORTO FRANCISCO GENTIL - E.P.E.
0 references
14 November 2023
0 references
Identifiers
POCI-01-0145-FEDER-029030
0 references